Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 5 | 2016 | 451 | 1.190 |
Why?
|
| Brain Mapping | 5 | 2016 | 228 | 1.060 |
Why?
|
| Brain | 8 | 2016 | 1493 | 0.950 |
Why?
|
| Brain Injuries | 3 | 2016 | 137 | 0.870 |
Why?
|
| Neural Pathways | 4 | 2016 | 97 | 0.700 |
Why?
|
| Memory Disorders | 1 | 2019 | 46 | 0.640 |
Why?
|
| Encephalitis | 1 | 2019 | 32 | 0.640 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2019 | 85 | 0.590 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2016 | 2052 | 0.580 |
Why?
|
| Behavior, Animal | 2 | 2013 | 218 | 0.540 |
Why?
|
| Visual Cortex | 1 | 2016 | 27 | 0.540 |
Why?
|
| Alcoholism | 1 | 2019 | 308 | 0.520 |
Why?
|
| Corpus Striatum | 1 | 2016 | 96 | 0.510 |
Why?
|
| Mindfulness | 1 | 2016 | 64 | 0.510 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2016 | 164 | 0.510 |
Why?
|
| Recovery of Function | 2 | 2016 | 267 | 0.500 |
Why?
|
| Prefrontal Cortex | 4 | 2019 | 115 | 0.500 |
Why?
|
| Behavior Therapy | 1 | 2016 | 163 | 0.490 |
Why?
|
| Frontal Lobe | 3 | 2014 | 66 | 0.480 |
Why?
|
| Testosterone | 2 | 2005 | 111 | 0.460 |
Why?
|
| Corpus Callosum | 2 | 2016 | 41 | 0.460 |
Why?
|
| Tobacco Use Disorder | 2 | 2014 | 245 | 0.450 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 43 | 0.430 |
Why?
|
| Rats | 7 | 2016 | 1915 | 0.420 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 2081 | 0.410 |
Why?
|
| Cognition Disorders | 1 | 2013 | 218 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 570 | 0.350 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2005 | 88 | 0.320 |
Why?
|
| Hydrocortisone | 2 | 2001 | 188 | 0.310 |
Why?
|
| Obesity | 1 | 2016 | 1191 | 0.310 |
Why?
|
| Male | 20 | 2016 | 27969 | 0.310 |
Why?
|
| Rest | 3 | 2016 | 43 | 0.270 |
Why?
|
| Animals | 11 | 2019 | 19771 | 0.260 |
Why?
|
| Adaptation, Psychological | 2 | 2005 | 264 | 0.260 |
Why?
|
| Rats, Wistar | 3 | 2013 | 179 | 0.260 |
Why?
|
| Hippocampus | 2 | 2019 | 243 | 0.260 |
Why?
|
| Hostility | 1 | 2005 | 17 | 0.250 |
Why?
|
| Acclimatization | 1 | 2005 | 10 | 0.250 |
Why?
|
| Personality | 1 | 2005 | 25 | 0.250 |
Why?
|
| Brain Concussion | 2 | 2015 | 28 | 0.240 |
Why?
|
| Fear | 1 | 2004 | 67 | 0.230 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2003 | 8 | 0.220 |
Why?
|
| Serotonin | 1 | 2003 | 63 | 0.220 |
Why?
|
| Nerve Net | 2 | 2015 | 93 | 0.210 |
Why?
|
| Energy Metabolism | 2 | 2015 | 351 | 0.200 |
Why?
|
| Appetitive Behavior | 1 | 2002 | 2 | 0.200 |
Why?
|
| Anti-Anxiety Agents | 1 | 2002 | 31 | 0.190 |
Why?
|
| Female | 13 | 2019 | 31235 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2002 | 96 | 0.190 |
Why?
|
| Child Abuse, Sexual | 1 | 2001 | 21 | 0.180 |
Why?
|
| Models, Animal | 1 | 2002 | 222 | 0.180 |
Why?
|
| Rats, Inbred SHR | 2 | 2016 | 5 | 0.170 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 37 | 0.160 |
Why?
|
| Saliva | 1 | 2000 | 96 | 0.160 |
Why?
|
| Seasons | 1 | 2000 | 130 | 0.160 |
Why?
|
| Anxiety | 1 | 2002 | 400 | 0.150 |
Why?
|
| Athletic Injuries | 2 | 2015 | 72 | 0.150 |
Why?
|
| Adult | 8 | 2016 | 15982 | 0.140 |
Why?
|
| Motor Activity | 2 | 2014 | 343 | 0.140 |
Why?
|
| Rats, Inbred WKY | 1 | 2016 | 11 | 0.140 |
Why?
|
| Somatosensory Cortex | 1 | 2016 | 16 | 0.140 |
Why?
|
| Maze Learning | 2 | 2014 | 52 | 0.130 |
Why?
|
| Ethanol | 1 | 2019 | 307 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2001 | 374 | 0.130 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 42 | 0.130 |
Why?
|
| Gene Expression | 1 | 2019 | 808 | 0.130 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 57 | 0.130 |
Why?
|
| Armadillo Domain Proteins | 1 | 2016 | 22 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 274 | 0.120 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 353 | 0.120 |
Why?
|
| Axons | 1 | 2016 | 121 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 303 | 0.120 |
Why?
|
| Phosphates | 1 | 2015 | 91 | 0.120 |
Why?
|
| Adolescent | 6 | 2015 | 5958 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 3222 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 292 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 196 | 0.120 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 13 | 0.120 |
Why?
|
| Program Evaluation | 1 | 2016 | 488 | 0.110 |
Why?
|
| Parietal Lobe | 1 | 2014 | 29 | 0.110 |
Why?
|
| Fish Oils | 1 | 2014 | 43 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 57 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2013 | 125 | 0.110 |
Why?
|
| Anisotropy | 1 | 2013 | 59 | 0.110 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 15 | 0.110 |
Why?
|
| Methylphenidate | 1 | 2013 | 19 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2014 | 204 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 68 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 685 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 639 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 64 | 0.100 |
Why?
|
| Schizophrenia | 1 | 2015 | 256 | 0.100 |
Why?
|
| Anger | 1 | 2012 | 23 | 0.100 |
Why?
|
| Reference Values | 2 | 2005 | 322 | 0.100 |
Why?
|
| Amygdala | 1 | 2012 | 81 | 0.100 |
Why?
|
| Psychometrics | 1 | 2013 | 359 | 0.090 |
Why?
|
| Humans | 11 | 2016 | 60133 | 0.090 |
Why?
|
| Middle Aged | 4 | 2016 | 16545 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2016 | 3131 | 0.080 |
Why?
|
| Mice | 2 | 2019 | 10340 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1470 | 0.070 |
Why?
|
| Young Adult | 5 | 2015 | 4395 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5264 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 3621 | 0.060 |
Why?
|
| Corticosterone | 1 | 2005 | 22 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 2614 | 0.060 |
Why?
|
| Aggression | 1 | 2005 | 57 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2004 | 28 | 0.060 |
Why?
|
| Foxes | 1 | 2004 | 3 | 0.060 |
Why?
|
| Odorants | 1 | 2004 | 17 | 0.060 |
Why?
|
| Pain Threshold | 1 | 2004 | 27 | 0.060 |
Why?
|
| Sexual Behavior, Animal | 1 | 2004 | 87 | 0.060 |
Why?
|
| Reaction Time | 1 | 2004 | 119 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 171 | 0.060 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2003 | 12 | 0.060 |
Why?
|
| United States | 1 | 2016 | 7609 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2004 | 336 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2005 | 522 | 0.050 |
Why?
|
| Motivation | 1 | 2004 | 270 | 0.050 |
Why?
|
| Buspirone | 1 | 2002 | 3 | 0.050 |
Why?
|
| Desipramine | 1 | 2002 | 3 | 0.050 |
Why?
|
| Chlordiazepoxide | 1 | 2002 | 3 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 45 | 0.050 |
Why?
|
| Yohimbine | 1 | 2002 | 8 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2002 | 20 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2002 | 20 | 0.050 |
Why?
|
| Clozapine | 1 | 2002 | 30 | 0.050 |
Why?
|
| Mesocricetus | 1 | 2002 | 93 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2002 | 44 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2002 | 28 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 51 | 0.050 |
Why?
|
| Cricetinae | 1 | 2002 | 376 | 0.050 |
Why?
|
| Arousal | 1 | 2000 | 42 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2000 | 60 | 0.040 |
Why?
|
| Cholesterol | 1 | 2000 | 255 | 0.040 |
Why?
|
| Child | 2 | 2013 | 4333 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 371 | 0.030 |
Why?
|
| Wallerian Degeneration | 1 | 2016 | 8 | 0.030 |
Why?
|
| Phosphorus Isotopes | 1 | 2015 | 7 | 0.030 |
Why?
|
| Nucleosides | 1 | 2015 | 11 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2001 | 1850 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2015 | 77 | 0.030 |
Why?
|
| Universities | 1 | 2015 | 152 | 0.030 |
Why?
|
| Creatine | 1 | 2014 | 26 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 195 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2014 | 29 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2014 | 99 | 0.030 |
Why?
|
| Athletes | 1 | 2015 | 97 | 0.030 |
Why?
|
| Locomotion | 1 | 2014 | 111 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2014 | 158 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2013 | 30 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 134 | 0.030 |
Why?
|
| Cerebellum | 1 | 2013 | 94 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1239 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2002 | 0.020 |
Why?
|
| Aged | 1 | 2000 | 13585 | 0.010 |
Why?
|